SEVENRICH CAPITAL Announces Group Participation of AHS Japan Corporation, Provider of the "Starband®" Cranial Remolding Helmet (World's No. 1 Market Share Product*1)

SEVENRICH CAPITAL Co., Ltd. (Headquarters: Shibuya-ku, Tokyo; Representative Director: Kenzo Hattori; hereinafter referred to as SEVENRICH CAPITAL), which supports corporate growth through business succession and M&A, announces that AHS Japan Corporation (Headquarters: Chuo-ku, Osaka; Representative Director: Hidetoshi Koga; hereinafter referred to as AHS Japan Corporation), the domestic provider of the world's No. 1 market share*1 cranial remolding helmet "Starband® (Starband)", has joined the SEVENRICH GROUP.

About AHS Japan Corporation's Participation in the SEVENRICH GROUP

AHS Japan Corporation provides the cranial remolding helmet "Starband®", developed by Orthomerica Inc. in the United States, within Japan, and is committed to providing treatment opportunities for cranial deformities in infants and young children.

This active-type product is a fully custom-made cranial remolding helmet designed to fit the unique head shape of each individual. It has been adopted in over 37 countries worldwide*2 and used by over 600,000 infants and young children cumulatively*3, making it the world's No. 1 market share*1 product.

Since its introduction in Japan in 2007, it has been provided for over 18 years, with a cumulative track record of over 14,000 users*4. Furthermore, in collaboration with over 45 university hospitals and core medical institutions nationwide*5, a provision system has been established through referrals from medical institutions.

https://www.ahsjapan.com/

SEVENRICH CAPITAL evaluated the company's track record of collaboration with medical institutions, its achievements in the field of cranial remolding treatment, and its growth potential, leading to the decision for AHS Japan Corporation to join the SEVENRICH GROUP.

Business Growth Support by SEVENRICH CAPITAL

SEVENRICH CAPITAL supports companies in joining the SEVENRICH GROUP through business succession and M&A, and provides hands-on support for corporate growth after their participation.

We will support the sustainable growth of companies by leveraging back-office functions such as accounting and tax, as well as the group network.

With the participation of AHS Japan Corporation in the group, we will promote the development of the business operation system, focusing on strengthening marketing and sales strategies, to further drive the company's business growth.

We will enhance information dissemination regarding the features and value of Starband®, such as its full custom-made design tailored to each individual's head shape and growth, and its abundant clinical results, as well as enrich information provision for parents.

In addition, we will advance the sophistication of sales activities to pediatricians, university hospitals, postpartum care facilities, etc., aiming to establish a system where treatment information reaches the appropriate parties at the right time.

This will lead to increased awareness of cranial remolding treatment and the creation of treatment opportunities.

<fi